NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,974 | -23.2% | 10,511 | +1.5% | 0.00% | – |
| Q2 2023 | $263,068 | -31.4% | 10,351 | -2.5% | 0.00% | -100.0% |
| Q1 2023 | $383,677 | -7.8% | 10,615 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $416,000 | +22.4% | 10,483 | +43.2% | 0.00% | 0.0% |
| Q3 2022 | $340,000 | -25.8% | 7,322 | -29.8% | 0.00% | 0.0% |
| Q2 2022 | $458,000 | -7.7% | 10,434 | +51.8% | 0.00% | 0.0% |
| Q1 2022 | $496,000 | -12.1% | 6,872 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $564,000 | -6.6% | 6,954 | +33.8% | 0.00% | 0.0% |
| Q3 2021 | $604,000 | -37.3% | 5,198 | -10.6% | 0.00% | -50.0% |
| Q2 2021 | $964,000 | +44.1% | 5,816 | +21.2% | 0.00% | 0.0% |
| Q1 2021 | $669,000 | -7.7% | 4,797 | +14.6% | 0.00% | 0.0% |
| Q4 2020 | $725,000 | +7.6% | 4,187 | -13.5% | 0.00% | 0.0% |
| Q3 2020 | $674,000 | +41.3% | 4,838 | +21.6% | 0.00% | 0.0% |
| Q2 2020 | $477,000 | +59.0% | 3,980 | +32.4% | 0.00% | +100.0% |
| Q1 2020 | $300,000 | – | 3,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |